Julian Clark

Drawing on many years of international experience Julian has played a key role in the translation of medical and health innovations having their genesis in academic or public research. Working from executive and governance positions in Europe, Asia, North America and Australia, he has commercialised many products and technologies including drugs, vaccines, devices, diagnostics, processes and analytical instruments. Through his consulting company, Julian has assisted more than 100 organisations in Australia with commercialisation. He has been a Director of more than 20 boards, including UniQuest, Cancer Trials Australia, BioGrid Australia, Nexpep, Alchemia, and MediTech. Recently he was Head of Business Development at WEHI, and previously CEO of Cancer Therapeutics CRC (Australia), Faulding Pharmaceuticals (Australia), Pharmacia LKB Biotechnology (Sweden), Biochrom (UK). Julian has a PhD from the University of Glasgow and was a post-doctoral fellow at the Karolinska Institute. A Doctor of the University (Uni SA) and Fellow of the Australia Academy of Technology and Engineering are recognition of his contributions to research commercialisation.